F8 and autoimmune hemolytic anemia: Further, a series of recent reports have indicated that the presentation of AHA in MDS is rare and complicated and that the patient may be more susceptible to a worse outcome.[25] In patients without a preexisting coagulopathy, AHA was confirmed by the presence of FVIII inhibitor and a decreased FVIII activity.